rs76537761

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_001032386.2(SUOX):​c.1358G>A​(p.Gly453Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0049 in 1,614,140 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 33 hom. )

Consequence

SUOX
NM_001032386.2 missense

Scores

9
7
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 8.83

Publications

10 publications found
Variant links:
Genes affected
SUOX (HGNC:11460): (sulfite oxidase) Sulfite oxidase is a homodimeric protein localized to the intermembrane space of mitochondria. Each subunit contains a heme domain and a molybdopterin-binding domain. The enzyme catalyzes the oxidation of sulfite to sulfate, the final reaction in the oxidative degradation of the sulfur amino acids cysteine and methionine. Sulfite oxidase deficiency results in neurological abnormalities which are often fatal at an early age. Alternative splicing results in multiple transcript variants encoding identical proteins. [provided by RefSeq, Jul 2008]
SUOX Gene-Disease associations (from GenCC):
  • isolated sulfite oxidase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_001032386.2
PP3
Multiple lines of computational evidence support a deleterious effect 8: BayesDel_noAF, Cadd, Eigen, MutationAssessor, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.026873618).
BP6
Variant 12-56004747-G-A is Benign according to our data. Variant chr12-56004747-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212329.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00372 (567/152292) while in subpopulation NFE AF = 0.00587 (399/68022). AF 95% confidence interval is 0.00539. There are 1 homozygotes in GnomAd4. There are 249 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 33 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SUOXNM_001032386.2 linkc.1358G>A p.Gly453Asp missense_variant Exon 5 of 5 ENST00000266971.8 NP_001027558.1
SUOXNM_000456.3 linkc.1358G>A p.Gly453Asp missense_variant Exon 6 of 6 NP_000447.2
SUOXNM_001032387.2 linkc.1358G>A p.Gly453Asp missense_variant Exon 4 of 4 NP_001027559.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SUOXENST00000266971.8 linkc.1358G>A p.Gly453Asp missense_variant Exon 5 of 5 2 NM_001032386.2 ENSP00000266971.3

Frequencies

GnomAD3 genomes
AF:
0.00373
AC:
567
AN:
152174
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00167
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00587
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00379
AC:
953
AN:
251378
AF XY:
0.00369
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.00249
Gnomad ASJ exome
AF:
0.0100
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000786
Gnomad NFE exome
AF:
0.00592
Gnomad OTH exome
AF:
0.00473
GnomAD4 exome
AF:
0.00502
AC:
7345
AN:
1461848
Hom.:
33
Cov.:
34
AF XY:
0.00492
AC XY:
3577
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.00137
AC:
46
AN:
33480
American (AMR)
AF:
0.00253
AC:
113
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
263
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000939
AC:
81
AN:
86258
European-Finnish (FIN)
AF:
0.000880
AC:
47
AN:
53408
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00587
AC:
6522
AN:
1111980
Other (OTH)
AF:
0.00444
AC:
268
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
509
1018
1528
2037
2546
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00372
AC:
567
AN:
152292
Hom.:
1
Cov.:
32
AF XY:
0.00334
AC XY:
249
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00166
AC:
69
AN:
41554
American (AMR)
AF:
0.00255
AC:
39
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0107
AC:
37
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00587
AC:
399
AN:
68022
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00528
Hom.:
4
Bravo
AF:
0.00378
TwinsUK
AF:
0.00836
AC:
31
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.00360
AC:
437
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00632
EpiControl
AF:
0.00622

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Sulfite oxidase deficiency Benign:3
Sep 16, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not specified Benign:2
Mar 23, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 12, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SUOX: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SUOX-related disorder Benign:1
Mar 29, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.48
BayesDel_addAF
Uncertain
0.10
D
BayesDel_noAF
Pathogenic
0.38
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.88
D;D;D;D;D
Eigen
Pathogenic
0.88
Eigen_PC
Pathogenic
0.83
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.027
T;T;T;T;T
MetaSVM
Uncertain
0.50
D
MutationAssessor
Pathogenic
3.1
M;M;M;M;M
PhyloP100
8.8
PrimateAI
Uncertain
0.55
T
PROVEAN
Pathogenic
-6.7
D;D;D;D;D
REVEL
Pathogenic
0.83
Sift
Uncertain
0.0020
D;D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D;D
Polyphen
1.0
D;D;D;D;D
Vest4
0.78
MVP
0.90
MPC
0.65
ClinPred
0.036
T
GERP RS
5.0
Varity_R
0.87
gMVP
0.91
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76537761; hg19: chr12-56398531; API